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ttp://dx.doi.org/10.1016/j.ajpath.2013.11.032Deﬁciencies in prolyl hydroxylase domain proteins (PHDs) may lead to the accumulation of hypoxia-
inducible factor-a proteins, the latter of which activate local angiogenic responses by paracrine mecha-
nisms. Here, we investigate whether a keratinocyte-speciﬁc PHD deﬁciency may promote vascular survival
and growth in a distantly located ischemic tissue by a remote signaling mechanism. We generated mice
that carry a keratinocyte-speciﬁc Phd2 knockout (kPhd2KO) and performed femoral artery ligation.
Relative to wild-type controls, kPhd2KO mice displayed improved vascular survival and arteriogenesis in
ischemic hind limbs, leading to the accelerated recovery of hindlimb perfusion and superior muscle
regeneration. Similar protective effects were also seen in type 1 and type 2 diabeticmice. Molecularly, both
abundance of hypoxia-inducible factor-1a protein and expression of vascular endothelial growth factor-A
were increased in epidermal tissues of kPhd2KO mice, accompanied by increased plasma concentration of
vascular endothelial growth factor-A. Contrary to kPhd2KO mice, which are PHD2 deﬁcient in all skin
tissues, localized kPhd2KO in hindlimb skin tissues did not have similar effects, excluding paracrine
signaling as a major mechanism. Conﬁrming the existence of remote effects, hepatocyte-speciﬁc Phd2
knockout also protected hind limbs from ischemia injury. These data indicate that vascular survival and
growth in ischemia-injured tissue may be stimulated by suppressing PHD2 in a remotely located tissue and
may provide highly effective angiogenesis therapies without the need for directly accessing target tissues.
(Am J Pathol 2014, 184: 686e696; http://dx.doi.org/10.1016/j.ajpath.2013.11.032)Supported by NIH grant 5R01EY019721 (G.-H.F.) and American Heart
Association Scientist Development grant 11SDG7580014 (K.T.).
Disclosures: None declared.Disrupted arterial blood ﬂow leads to ischemia diseases such
as myocardial infarction and gangrene, which are devastating
disorders with high rates of morbidity and mortality.1e3 In
recent years, the incidence of ischemia diseases has been on
the rise because of the aging population and increased
prevalence of diabetes mellitus.3e5 Thus, medical needs are
urgent for novel vascular therapies directed at restoring blood
ﬂow to affected tissues.6e8 Some examples of angiogenesis
therapies under development include local or systemic
administration of angiogenic factors and cell therapies that
use bone marrowe or peripheral bloodederived mono-
nuclear cells.7 Despite intensive efforts, successful clinical
applications remain to be found.8
Prolyl hydroxylase domain proteins (PHDs) may represent
a novel class of targets for angiogenesis therapy.9e11 PHD1,
PHD2, and PHD3 are Feþþ and 2-oxoglutarateedependent
dioxygenases present in both the cytoplasm and nuclei.12e16stigative Pathology.
.In addition, a related transmembrane protein termed P4HTM
is present in the endoplasmic reticulum.17,18 In adequately
oxygenated cells, PHDs use oxygen as a substrate to hy-
droxylate two speciﬁc prolyl residues in hypoxia inducible
factor (HIF)-a proteins, tagging them for von Hippel Lindau
proteinedependent polyubiquitination and proteasomal
degradation.12e14
HIF-1a and HIF-2a are transcription factors that accu-
mulate under hypoxia and form transcriptionally active het-
erodimers with the HIF-1b subunit.19e24 HIF heterodimers
activate the transcription of a large number of target genes
which encode proteins involved in hypoxia adaptation,
including glycolytic enzymes,25 erythropoietin,26e28 and
Table 1 PCR Primers for Genotyping
Gene/transgene Forward primer Reverse primer
Phd1 50-CTCTAACAAGCACAAACCATCATT-30 50-ACTGGTGAAGCCTGTAGCCTGTC-30
Phd2 50-AACTCCGCCAAGCAGGTCAGAA-30 50-TCAACTCGAGCTGGAAACC-30
Phd3 50-CTCTTCCTTCCTTCCTCTTAG-30 50-CCACGTTAACTCTAGAGCCACTGA-30
KRT14CreERT 50-GCGCCTGAGCTGCCCACACTA-30 50-CACCCCAACATCCCCATCAAAGAG-30
AlbCre 50-GGCTGGACCAATGTAAATA-30 50-GCTGAGTGGTTCGGGGAGTT-30
Remote Signaling for Vascular Protectionangiogenic factors.20,29 A prototypic example of hypoxia-
induced angiogenic factor is the vascular endothelial
growth factor (VEGF)-A that mediates vascular endothelial
cell (EC) survival, proliferation, and migration mostly by
activating VEGF receptor-2.20,30
To date, angiogenesis in response to tissue hypoxia or
HIF-a overexpression has been studied within the frame-
work of paracrine signaling mechanisms wherein hypoxia-
induced angiogenic factors interact with cognate cell
surface receptors on nearby ECs.31,32 In this study, we
demonstrate that keratinocyte-speciﬁc Phd2 knockout
(kPhd2KO) promotes vascular survival, arteriogenic
remodeling, and muscle regeneration in a mouse hindlimb
ischemia model. We present compelling evidence that such
effects are mediated by a humoral mechanism wherein
elevated plasma concentration of VEGF-A may at least
partially contribute to the beneﬁcial effects of skin Phd2
knockout.
Materials and Methods
Mice
All animal procedures were approved by the Animal Care
Committee at the University of Connecticut Health Center in
compliance with Animal Welfare Assurance. Phd2f/f/
KRT14CreERT, Phd2f/f/Phd3f/f/KRT14CreERT, and Phd1f/f/
Phd2f/f/Phd3f/f/KRT14CreERTmicewere generated by crossing
ﬂoxed (f ) Phdmice33with a transgenic line expressingCreERT
under the control of the human keratin 14 promoter
(KRT14CreERT mice34; The Jackson Laboratory, Bar Harbor,
ME; stock number 005107). Unless indicated otherwise,
disruption of ﬂoxed alleles was induced at 6 to 7 weeks of age
by oral gavage of tamoxifen (Sigma-Aldrich, St. Louis, MO),
performed daily for 5 days at 80 mg/kg of body weight. After
tamoxifen treatment, Phd2f/f/KRT14CreERT, Phd2f/f/Phd3f/f/
KRT14CreERT, and Phd1f/f/Phd2f/f/Phd3f/f/KRT14CreERTmice
were designated as kPhd2KO, kDKO, and kTKO mice,
respectively. Phd2f/f mice were treated in parallel as de facto
wild-type (WT) control.Table 2 RT-PCR Primers
mRNA Forward primer
Phd1 50-ACCGCGCAGCATTCGTG-30
Phd2 50-GCCCGGCTGCGAAACCATC-30
Phd3 50-CTGCGTGCTGGAGCGAGTCAA-30
The American Journal of Pathology - ajp.amjpathol.orgTo induce localized Phd2 knockout in hindlimb skin tissues,
4-hydroxytamoxifen (4-OHT; Sigma-Aldrich) was applied
topically to left thigh skin. In brief, the left thigh was shaved,
and a single dose of 4-OHT (2 mL at 5 mg/mL in dimethyl
sulfoxide) was directly applied to the shaved skin surface. After
10 minutes, 4-OHT was completely cleaned away with saline.
The resulting mice were designated as kPhd2KOlh mice to
indicate localized knockout in the left hind limb.
Phd2f/f/AlbCre (AlbPhd2KO) mice were generated by
crossing Phd2-ﬂoxed mice with AlbCre mice35 (The Jack-
son Laboratory; stock number 003574), which express
constitutively active Cre under the control of the mouse
albumin enhancer/promoter.
All genotypes were determined by PCR of ear punch
DNA with the use of primers listed in Table 1.
FAL and Laser Doppler Imaging
Femoral artery ligation (FAL) was performed on the left leg
of 10- to 12-week-old male mice or at indicated ages for
speciﬁc experiments. Under anesthesia, the femoral artery
was ligated distal to the inguinal ligament and proximal to
the saphenous-popliteal bifurcation. After all side branches
were occluded by electrical cautery, the femoral artery was
separated from muscles, and the ligated segment was
excised. Skin incisions were closed with a 6-0 nylon suture.
Hindlimb blood ﬂow in the paw area was measured with
a Moor Infrared Laser Doppler Imager (Moor Instruments,
Wilmington, DE) immediately before and after FAL (pre
and day 0, respectively) and at various time points thereafter
(days 3, 7, 14, and 28).
Histological Analysis
Hindlimb muscle tissues were ﬁxed for 24 hours in zinc
ﬁxative (100 mmol/L Tris-HCl, pH7.4, 0.5 mg/mL calcium
acetate, 5 mg/mL zinc acetate, and 5 mg/mL zinc chloride),
and equilibrated overnight in 30% sucrose. Fixed and equili-
brated tissues were embedded in OTC compound and cut at 10
mm. Skin tissues were ﬁxed in the same manner, embedded inReverse primer
50-GGGGCTGGCCATTAGGTAGGTGTA-30
50-TCGCTCGCTCATCTGCATCAAAAT-30
50-TCATGTGGATTCCTGCGGTCTG-30
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Table 3 qPCR Primers
mRNA Forward primer Reverse primer
Phd1 50-CATCAATGGGCGCACCA-30 50-GATTGTCAACATGCCTCACGTAC-30
Phd2 50-TAAACGGCCGAACGAAAGC-30 50-GGGTTATCAACGTGACGGACA-30
Phd3 50-CTATGTCAAGGAGCGGTCCAA-30 50-GTCCACATGGCGAACATAACC-30
VEGF-A 50-GCACATAGGAGAGATGAGCTTCC-30 50-CTCCGCTCTGAACAAGGCT-30
PlGF 50-CCTGTCTGCTGGGAACAACTCA-30 50-CACCTCATCAGGGTATTCATCCAAG-30
TNFa 50-AAGCCTGTAGCCCACGTCGTA-30 50-GGCACCACTAGTTGGTTGTCTTTG-30
Ang1 50-CACATAGGGTGCAGCAACCA-30 50-CGTCGTGTTCTGGAAGAATGA-30
Ang2 50-CATCTGCAAGTGTTCCCAGA-30 50-AAGTTGGAAGGACCACATGC-30
PDGFB 50-CAAAGGCAAGCACCGAAAGTTTA-30 50-CCGAATCAGGCATCGAGACA-30
SDF1 50-CAGCCGTGCAACAATCTGAAG-30 50-CTGCATCAGTGACGGTAAACC-30
IL-1b 50-CTGTGACTCATGGGATGATGATG-30 50-GCCTGTAGTGCAGTTGTCTAAT-30
Ccl-2 PPM03151F (Qiagen) PPM03151F (Qiagen)
b-actin 50-GGCTGTATTCCCCTCCATCG-30 50-CCAGTTGGTAACAATGCCATGT-30
Ang, angiopoietin 5; Ccl-2, chemokine (C-C motif) ligand 2; PlGF, placental growth factor; PDGFB, platelet-derived growth factor B; SDF1, stromal cell
derived factor 1; TNFa, tumor necrosis factor a.
Takeda et alparafﬁn after dehydration, and cut at 5 mm. Sections were used
for H&E and Gomori trichrome staining, or immunohisto-
chemical (IHC) and immunoﬂuorescence (IF) staining. For
IHC or IF staining, sectionswere subject to antigen retrieval by
heating in Citrate Buffer and were blocked with Power Block
Universal Blocking Reagent (BioGenex, San Roman, CA).Figure 1 Accelerated recovery of hindlimb perfusion in kPhd2KO mice. A and
bars) and kPhd2KO (black bars) mice. C: Left-to-right perfusion ratios for individu
group indicated at the top. D: Correlation analysis between left-to-right perfusion
perfusion ratio distribution on day 3. Values below the x axis are different ranges o
by arrows. nZ 10 (A, B, and D, WT); nZ 7 (A, B, and D, kPhd2KO); nZ 21 (C a
yyP < 0.01 by ANOVA (A and B). Day 0, immediately after FAL; Pre, immediately
688For IHC staining, sections were incubated with antie
HIF-1a (Novus Biologicals, Littleton, CO; NB100-134), anti-
CD31 (Santa Cruz Biotechnology, Santa Cruz, CA; sc-1506),
or anti-CD45 (BioLegend, San Diego, CA; number 103101).
Signals were detected by staining with biotinylated secondary
antibodies in conjunction with avidin-biotin complex andB: Measurement of blood perfusion by laser Doppler imaging in WT (white
al mice are plotted for indicated time points, with average values for each
ratio on day 3 and gastrocnemius muscle weight on day 28. E: Histogram for
f left-to-right perfusion ratios, with modal (most frequent) ranges indicated
nd E, WT); nZ 15 (C and E, kPhd2KO). *P < 0.05 by Student’s t-tests (C);
before FAL.
ajp.amjpathol.org - The American Journal of Pathology
Remote Signaling for Vascular Protectiondiaminobenzidine kits (Vector Laboratories, Burlingame,
CA). For IF staining, sections were incubated with each of the
following pairs of primary and secondary antibodies: anti-
CD31 (Santa Cruz Biotechnology; sc-1506) and Alexa Fluor
488econjugated anti-goat IgG (Life Technologies, Carlsbad,
CA; A-11055), anti-Ki67 (BioLegend; number 652401) and
cyanine 3econjugated anti-rat IgG (Jackson ImmunoResearch
Laboratories Inc., West Grove, PA; 712-166-153), and antie
activated caspase 3 (Abcam, Cambridge, MA; ab13847) and
Alexa Fluor 594econjugated anti-rabbit IgG (Life Technol-
ogies; A-11072). IHC- or IF-stained sections were visualized
by bright ﬁeld light microscopy or laser confocal microscopy,
respectively, and quantiﬁed with the assistance of ImageJ
software version 1.46e (NIH, Bethesda, MD).
Forwhole-mount staining, skin specimensweredigestedwith
3mg/mLdispase II (RocheDiagnostics,Mannheim,Germany),
and dermal and epidermal layers were physically separated.
Isolated dermal tissueswereﬁxed in 4%paraformaldehyde for 1
hour and subsequently in acetone for 20 minutes. Fixed dermal
tissues were double stained with Alexa Fluor 488econjugated
anti-mouse CD31 antibody (BioLegend; 102513) and allophy-
cocyanin-conjugated anti-mouse CD11b antibody (BioLegend;
101211). Stained specimens were mounted on slides and
examinedby confocal lasermicroscopy.Resultswere quantiﬁed
with the assistance of ImageJ software.
Molecular Analysis
RT-PCR and real-time quantitative PCR (qPCR) analyses
were performed for RNA samples isolated from the epidermal
layer of skin tissues. Primer sequences for RT-PCR andFigure 2 Reduced ischemia injury and improved arterial growth in thigh musc
antieactivated caspase 3 IHC staining. Adductor muscle cross-sections used in th
from necrotic areas. In kPhd2KO mice, necrotic areas were not found in adductor m
staining of adductor muscles 3 days after FAL. Images in WT group were taken
kPhd2KO sections were taken from random areas. E and F: Anti-CD31 and anti-Ki6
cells are indicated by arrows. Images were taken from similar areas as described fo
with arterial lumens indicated by arrows. H: Measurements of arterial lumen diame
and H) by Student’s t-tests. Scale bars: 100 mm (A and B); 20 mm (CeF); 10 mm
The American Journal of Pathology - ajp.amjpathol.orgqPCR are listed in Tables 2 and 3, respectively. All qPCR
signal intensities were normalized against that of beta-actin.
VEGF-A protein levels in skin lysates and plasma were
determined by adapting the manufacturer’s instructions of a
VEGF-A ELISA kit (R&D Systems, Emeryville, CA).
Induction of Diabetes
To induce type 1 diabetes, 6- to 7-week-old male Phd2f/f/
KRT14CreERT and Phd2f/f mice were deprived of food for 4
hours and injected intraperitoneally with a single dose of
streptozotocin (STZ; Sigma-Aldrich; 150 mg/kg in citrate
buffer, pH 4.5). Four days after STZ injection, mice with ad
libitum blood glucose concentrations >400 mg/dL were
subject to further experimentation. Oral gavage of tamoxifen
was performed 3 weeks after STZ injection, and FAL was
performed after another 7 weeks.
Type 2 diabetes-like symptoms were induced by high-fat
diet (HFD; 60/Fat Adjusted Calorie Diet; Harlan Labora-
tories, Inc., Indianapolis, IN; catalog number TD.06414).
Speciﬁcally, tamoxifen-treated Phd2f/f (WT) and kPhd2KO
male mice were maintained on HFD for 4 months, starting
from 7 weeks of age, and were subjected to FAL afterward.
Statistical Analysis
Statistical differences were analyzed by two-tailed Student’s
t-tests or two-way analysis of variance (ANOVA). Data are
shown as means  SEM. All n values refer to the number of
mice per group. P < 0.05 was considered to be statistically
signiﬁcant. Perfusion mode values were identiﬁed by plottingles of kPhd2KO mice. A and B: Detection of apoptotic myocytes (brown) by
is assay were prepared 3 days after FAL. Images in the WT group were taken
uscle sections. C and D: Anti-CD31 and antieactivated caspase 3 double IF
and quantiﬁed from areas adjacent to severely necrotic tissues. Images in
7 IF staining of adductor muscle sections 3 days after FAL. Double-positive
r C and D. G: H&E-stained sections of semimembranosus muscles on day 28,
ters. nZ 7 (A, B, G, and H); nZ 3 (CeF). *P < 0.05, **P < 0.01 (B, D, F,
(G).
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Takeda et alhistogram of mice in different ranges of left-to-right perfusion
ratio. Correlation between perfusion at day 3 and gastrocne-
mius muscle weight at day 28 was evaluated by calculating
coefﬁcient of determination R2 value of a linear-ﬁtted curve.
Results
Accelerated Recovery of Hindlimb Perfusion in
kPhd2KO Mice after FAL
Keratinocyte speciﬁc Phd2 knockout was induced by oral
gavage of tamoxifen in 6- to 7-week-old Phd2f/f/KRT14CreERT
mice. Efﬁcient epidermal Phd2 disruption was conﬁrmed by
genomic PCR and RT-PCR (Supplemental Figure S1, A and
B). In kPhd2KOmice, Phd2-speciﬁc primers detected only the
deleted allele, whereasPhd1- orPhd3-speciﬁc primers detected
only WT bands. According to qPCR, epidermal Phd2 mRNA690in kPhd2KO mice was reduced to 7.8% of ﬂoxed (WT) con-
trols, whereas Phd3 mRNA was signiﬁcantly increased
(Supplemental Figure S1C). No targeted Phd2 band (del) was
present in the hindlimb skeletal muscle and a variety of other
organs and tissues, including the heart, lung, kidney, liver, and
spleen (Supplemental Figure S2). Thus, in kPhd2KO mice,
efﬁcient Phd2 knockout occurred exclusively in the epidermal
tissues.
To assess the effect of epidermal PHD2 deﬁciency on
arteriogenesis in muscular tissues, we induced hindlimb
ischemia by FAL in the left leg of 10-week-old Phd2f/f (WT)
and kPhd2KO mice and monitored blood ﬂow by laser
Doppler imaging over a 4-week time frame. Hindlimb
perfusion recovered signiﬁcantly faster in the kPhd2KO
group, with the left-to-right hindlimb perfusion ratio
reaching 0.65 by day 28 after FAL, whereas WT mice had
an average ratio of 0.33 (Figure 1, A and B).Figure 3 Differential skin angiogenesis among
WT, kPhd2KO, kDKO, and kTKO mice without
operation by FAL. A: Paw redness in kDKO and
kTKO, but not WT and kPhd2KO, mice 4 weeks after
tamoxifen treatment. B: Laser Doppler imaging of
paws. C: Whole-mount anti-CD31 (green) and anti-
CD11b (red) double IF staining of the dermal layer
of skin tissues. D: Blood perfusion values in
different groups of mice relative to WT, the latter
of which was set at onefold. E: Number of CD31þ
vascular branching points per high power ﬁeld. F:
CD11bþ cells per unit area. n Z 6 (A, B, and D);
nZ 3 (C, E, and F). *P < 0.05, **P < 0.01 (DeF)
by Student’s t-tests. Scale bars: 100 mm (C).
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Remote Signaling for Vascular ProtectionTo determine whether improved perfusion occurred as an
early time point after FAL, we compared left-to-right
perfusion ratios at day 3 after FAL by a dot plotting
method. As shown in Figure 1C, althoughWT and kPhd2KO
mice had the same low perfusion ratio of 0.07 immediately
after FAL (day 0), kPhd2KO mice recovered much faster,
with perfusion ratio reaching 0.15 by day 3, whereas the
average perfusion ratio in the WT group was signiﬁcantly
lower (Figure 1C). Hindlimb perfusion on day 3 was well
correlated to calf muscle weight on day 28 (R2 Z 0.6426)
(Figure 1D), indicating that higher perfusion rates at earlier
stages supported subsequent muscle regeneration.
However, perfusion values did vary substantially among
different mice within the same group. Hence, we generated
a histogram by plotting number of mice versus different
perfusion ranges. This effort identiﬁed perfusion ranges that
contained the largest number of mice for each group (mode
values), which were 0.06 to 0.10 in WT and 0.16 to 0.20 in
kPhd2KO mice (Figure 1E). In subsequent studies, mice
within modal ranges were further examined by histological
and molecular approaches.The American Journal of Pathology - ajp.amjpathol.orgImproved Microvascular Survival, Arteriogenesis, and
Hindlimb Muscle Protection in kPhd2KO Mice
We performed histological analyses of adductor muscle cross-
sections 3 days after FAL. By antieactive caspase 3 IHC
staining, widespread myocyte apoptosis was detected in the
WT group but not in kPhd2KO mice (Figure 2, A and B).
Similar results were found for capillary ECs by double IF
staining for CD31 and active caspase 3 (Figure 2, C and D).
Because regeneration of ischemia-injured tissues typically
involves active cell proliferation to replace lost tissues, we also
examined cell proliferation in hindlimb tissues by anti-CD31
and anti-Ki67 IF staining. Proliferative ECs were abundantly
present inWTmice (Figure 2, E and F), which was suggestive
of an adaptive response to severe tissue ischemia and capillary
loss. In kPhd2KO mice, however, hindlimb tissues were
mostly quiescent, and proliferative cells, including prolifera-
tive ECs, were scarce. When examined at day 28 after FAL,
kPhd2KO mice were also found to display superior features
over WT controls. In histological sections of semi-
membranosus muscles, arterial lumens were signiﬁcantlyFigure 4 Differential calf muscle regeneration
and toe protection among WT, kPhd2KO, kDKO, and
kTKO mice. All sections were from gastrocnemius
muscles 28 days after FAL. A and B: Anti-CD31
staining and quantiﬁcation of CD31þ capillaries.
C and D: H&E-stained sections and quantiﬁcation
of areas occupied by healthy (non-necrotic) mus-
cle bundles. Necrotic muscle tissues were excluded
from quantiﬁcation. Examples of non-necrotic
muscle bundles are demarcated by dotted lines
in C. E and F: Gomori trichrome-stained gastroc-
nemius muscle sections and quantiﬁcation of
ﬁbrotic area (blue). G and H: Anti-CD45estained
sections and number of CD45þ cells (brown dots)
per high power ﬁeld. I: Paw and foot necrosis 28
days after FAL; blackened nails or nail loss are
indicated by arrows. J: Necrosis scores from day
0 to day 28. nZ 7 to 10 (AeJ). *P < 0.05 (F and
H), **P < 0.01 (D) by Student’s t-tests; yyP < 0.01
(J) by ANOVA). Scale bars: 15 mm (A); 50 mm (C
and G); 100 mm (E).
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Takeda et allarger in kPhd2KO mice (Figure 2, G and H). These ﬁndings
indicated that keratinocyte-speciﬁc Phd2 knockout protected
thigh microvessels and muscle tissues from ischemia injury
and improved subsequent arteriogenesis.Differential Skin Angiogenesis among WT, kPhd2KO,
kDKO, and kTKO Mice
In addition to PHD2, PHD1 and PHD3 are also known to
participate in the regulation of HIF-a stability.16,36 To eval-
uate the effects of keratinocyte-speciﬁc Phd2/Phd3 double
knockout and Phd1/Phd2/Phd3 triple knockout, we gener-
ated kDKO and kTKOmice by oral gavage ofPhd2f/f/Phd3f/f/
KRT14CreERT and Phd1f/f/Phd2f/f/Phd3f/f/KRT14CreERT
mice, respectively (Supplemental Figure S1, AeC). In
contrast to kPhd2KO mice that had indistinguishable
external appearance from WT mice, both kDKO and kTKO
mice displayed conspicuous skin redness (Figure 3A). In
mice without any surgical operation, hindlimb perfusion in
kDKO and kTKO but not kPhd2KO mice were signiﬁcantly
elevated from WT levels, likely reﬂecting increased perfu-
sion in the skin (Figure 3B). Indeed, anti-CD31 IF staining of
skin tissues showedmultifold increases in vascular branching
points in kDKO or kTKO mice (Figure 3C). Furthermore,
signiﬁcant inﬁltration of CD11bþ macrophages was foundFigure 5 Molecular analysis for HIF-1a protein levels and angiogenic factor
quantiﬁcation of positive HIF-1a areas. C: qPCR of epidermal RNA from WT, kPhd2
including WT values, were normalized against b-actin and shown as relative values
kTKO mice. Shown are picograms of VEGF-A per 50 mg total skin protein. E: Qua
ELISA. nZ 4 to 5 (A and B); nZ 3 (C and E, kTKO); nZ 4 (D and E, kDKO); nZ
t-tests. Scale bar Z 10 mm.
692only in kDKO and kTKOmice (Figure 3C). Quantitative data
of the above-mentioned observations are presented in
Figure 3, DeF.Facilitated Muscle Regeneration in kPhd2KO But Not
kDKO or kTKO Mice
At 28 days after FAL, capillaries had clearly different dis-
tribution patterns between gastrocnemius muscle sections in
WT and kPhd2KO mice. In WT mice, capillaries were
irregularly clustered within necrotic tissues (Figure 4A). By
contrast, capillaries in kPhd2KO mice were regularly inter-
calated between fully intact myocytes (Figure 4A). Thus,
although the overall capillary densities were similar between
WT and kPhd2KO mice, the distribution pattern in the latter
appeared much healthier (Figure 4B). It is important to note
that in mice without any surgical operation, vascular
morphology in hindlimb muscles was similar between WT
and kPhd2KO groups (Supplemental Figure S3, AeD),
excluding the possibility that differential vascular morphol-
ogies were already present before surgery.
In H&E-stained cross-sections of the calf (gastrocnemius)
muscle, intact muscle ﬁbers occupied just more than one-half
of the total areas in WT mice, with the rest of the area con-
taining necrotic tissues. In kPhd2KO mice, intact muscleexpression. A and B: AntieHIF-1a IHC staining of epidermis sections and
KO, kDKO, and kTKO mice 4 weeks after tamoxifen administration. All data,
to WT. D: VEGF-A ELISA for total skin lysates from WT, kPhd2KO, kDKO, and
ntiﬁcation of plasma VEGF-A in WT and kPhd2KO, kDKO, and kTKO mice by
14 (E, WT), nZ 5 (E, kPhd2KO). *P < 0.05, **P < 0.01 (BeE) by Student’s
ajp.amjpathol.org - The American Journal of Pathology
Figure 6 Evidence for the existence of a remote signaling mechanism.
A: Measurement of paw perfusion by laser Doppler imaging in WT and
kPhd2KOlh mice, both topically treated with 4-OHT on the left thigh. B:
Left-to-right perfusion ratios in WT and kPhd2KOlh mice. C: Laser Doppler
imaging for WT and AlbPhd2KO mice. D: Left-to-right perfusion ratios in WT
and AlbPhd2KO mice. nZ 5 (A, WT); nZ 6 (A, kPhd2KOlh; C, AlbPhd2KO);
n Z 8 (C, WT). *P < 0.05 (B and D, by ANOVA). Day 0, immediately after
FAL; Pre, immediately before FAL.
Remote Signaling for Vascular Protectionstructures cover essentially the entire section areas (Figure 4,
C and D). In sections stained with Gomori trichrome, 12.5%
of total tissue area was found to be collagen-positive ﬁbrotic
scars in WT mice, whereas the corresponding value in
kPhd2KO mice was only 1.1% (Figure 4, E and F). By anti-
CD45 IHC staining, massive leukocyte inﬁltration was found
in WT but not kPhd2KO mice (Figure 4, G and H).
In agreement with improved vascular and muscular
integrity, there was virtually no foot necrosis in kPhd2KO
mice that had undergone FAL. For quantiﬁcation, we
determined foot necrosis scores, deﬁned as the number of
toes with blackened or lost nails. As shown in Figure 4, I
and J, the WT group had an average necrosis score of 2
between days 7 and 28, whereas the corresponding score in
kPhd2KO mice remained at 0.
In contrast, kDKO and kTKO mice that had undergone
FAL failed to display improved vascular andmuscle integrity,
displaying irregularly arranged microvessels in necrotic
muscle tissues, conspicuous amounts of nonmuscular and
ﬁbrotic tissues, as well as massive leukocyte inﬁltration into
ischemia-damaged hindlimb tissues (Figure 4, AeH).
Consistent with these ﬁndings, toes in kDKO and kTKOmice
were not resistant to ischemic damage (Figure 4, I and J).
Molecular Analysis and Evidence for a Remote
Signaling Mechanism
To understand molecular mechanisms that regulate vascular
growth, we investigated HIF-1a protein levels and angiogenic
factor expression in epidermal tissues. IHCstainingof epidermal
sections indicated that HIF-1a protein levels progressively
increased in the order of WT < kPhd2KO < kDKO < kTKO
(Figure 5, A and B). qPCR also ranked epidermal VEGF-A
mRNA abundance in the order of WT (1.0-fold) < kPhd2KO
(2.3-fold)< kDKO (5.9-fold)< kTKO (18.8-fold) (Figure 5C).
In addition to VEGF-A, we also performed qPCR for another 8
RNAspecies that encodevarious angiogenic factors, but noneof
them were increased in kPhd2KO mice, although placental
growth factor was increased in kTKOmice (Figure 5C). VEGF-
A ELISA of skin tissue lysates conﬁrmed the same order of
VEGF-A protein abundance as its mRNA levels, with WT
having the lowest andkTKOhaving thehighest levels ofVEGF-
A (Figure 5D). We also quantiﬁed plasma VEGF-A levels by
ELISA. As shown in Figure 5E, circulating VEGF-A in
kPhd2KOmice was increased by approximately 43.3% than in
WT controls. Surprisingly, no increased VEGF-A was detected
in plasma samples from kDKO or kTKO mice (Figure 5E).
We wondered if improved hindlimb recovery in
kPhd2KO mice was due to paracrine actions of angiogenic
factors secreted from adjacent PHD2-deﬁcient hindlimb
skins. To address this issue, we induced Phd2 disruption in
left hindlimb skin tissues by topical application of 4-OHT to
Phd2f/f/KRT14CreERT mice (Supplemental Figure S4A),
resulting in kPhd2KOlh mice whereby lh refers to left hind
limb. PCR analysis revealed essentially complete Phd2
knockout in left hindlimb skin tissues in kPhd2KOlh miceThe American Journal of Pathology - ajp.amjpathol.orgbut not from untreated skins anywhere else (Supplemental
Figure S4B). After FAL, kPhd2KOlh mice failed to show
any improved perfusion over WT mice (Figure 6, A and B),
suggesting that paracrine mechanisms played negligible
roles in accelerating arteriogenesis in kPhd2KO mice and
that a remote effect might be involved.
To further test the possible existence of a remote signaling
mechanism, we investigated whether the recovery of hindlimb
perfusion could be accelerated by PHD2 deﬁciency in a
distantly located organ. We chose to perform this test in
AlbPhd2KOmice, which were PHD2 deﬁcient in hepatocytes
(Supplemental Figure S5, AeC). Note the presence of the del
band only in the liver (Supplemental Figure S5B). When
housed under normal conditions, AlbPhd2KO mice were
indistinguishable from ﬂoxed mice, and their liver histology,693
Takeda et alas well as vascular morphology, was not grossly changed
(Supplemental Figure S5, D and E). After FAL, hindlimb
perfusion recovered substantially faster in AlbPhd2KO mice
(Figure 6, C and D). Given the vital function of the liver itself,
it is unlikely that hepatic PHD2 per se would be a therapeutic
target for angiogenesis; nonetheless, our ﬁndings indicate the
existence of a remote trans-tissue mechanism whereby PHD2
deﬁciency in a speciﬁc tissue may improve vascular and tissue
repair in a distant organ.
PHD2-Deﬁcient Skin Protects Hind Limb under Diabetic
Conditions
One of the most common pathological conditions that leads
to vascular destruction and tissue ischemia is diabetes.37e39 To
test if kPhd2KO improves ischemic tissue perfusion under
diabetic conditions, we induced diabetes in WT and kPhd2KO
mice with STZ. After FAL, hindlimb perfusion recovery was
signiﬁcantly faster in kPhd2KOmice (Figure 7A), accompanied
bycomplete lackof toenecrosis (Figure 7B).Besides improving
hindlimb perfusion and protecting toes from necrotic damages,
kPhd2KO also helped maintain normal structural organization
of epidermal tissues under prolonged hyperglycemia, whereas
WT, kDKO, and kTKO mice all developed hyperkeratosis
under similar conditions (Supplemental Figure S6).
Because vascular repair is frequently compromised in
patients with type 2 diabetes,40,41 we asked if keratinocyte-
speciﬁc PHD2 deﬁciency might be beneﬁcial in a mouse
model of type 2 diabetes. We induced type 2 diabetes in
kPhd2KO mice by HFD (Supplemental Figure S7, A and B)
and performed FAL. As shown in Figure 7, C and D,694kPhd2KO mice demonstrated accelerated perfusion recov-
ery and negligible toe necrosis.
Discussion
A Possible Positive Feedback Cycle between
Microvascular Survival and Arteriogenic Remodeling
Here, we provide evidence that keratinocyte-speciﬁc PHD2
deﬁciency may promote EC and myocyte viability and may
accelerate vascular growth andmuscle regeneration. Reduced
number of proliferative and apoptotic ECs as early as 3 days
after FAL raised the possibility that keratinocyte-speciﬁc
PHD2 deﬁciency protected hindlimbmicrovascular ECs from
ischemia-inﬂicted apoptosis. Dramatically improved micro-
vascular viability early after surgery might accelerate subse-
quent arteriogenic remodeling by making microvascular
building blocks more readily available. In turn, accelerated
arteriogenic remodeling because of superior microvascular
viabilitymaymoderate hindlimb ischemia, whichmay further
improve EC viability. Thus, a positive feedback cycle might
ensue, leading to the formation of larger arterial branches and
improved myocyte survival and regeneration.
A Potential Role of Plasma VEGF-A
The precise mediator for the observed protective effects re-
mains to be conﬁrmed, but our data partially support a role for
increased plasma VEGF-A. VEGF-A has established roles in
angiogenesis, EC survival, and arteriogenesis, and its effects
on vascular development in mouse embryos are known to beFigure 7 Accelerated perfusion recovery and
superior toe protection in diabetic kPhd2KO mice.
A: Laser Doppler images and quantiﬁcation of left-
to-right perfusion ratio in STZ-treated WT and
kPhd2KO mice. B: Foot necrosis scores for STZ-
treated WT and kPhd2KO mice between days
0 and 28 after FAL. C: Laser Doppler images and
quantiﬁcation of left-to-right perfusion ratios in
HFD-treated WT and kPhd2KO mice. D: Foot ne-
crosis scores in HFD-treated WT and kPhd2KO mice.
nZ 6 (A, WT); nZ 7 (A, kPhd2KO; B, WT); nZ 8
(BeD, kPhd2KO); nZ 9 (C and D, WT). *P < 0.05.
Day 0, immediately after FAL; Pre, immediately
before FAL.
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Remote Signaling for Vascular Protectiondose sensitive.42e44 Increased plasma concentration of
VEGF-A in kPhd2KO mice agrees well with improved
vascular integrity and accelerated perfusion recovery.
The failure of kDKOand kTKO to reduce ischemia damage
correlates with the lack of increased plasma VEGF-A in these
mice. It is unclear why there was a discrepancy between
VEGF-A expression data in the skin and ELISA data for
plasma samples, but dramatically increased microvessels in
kDKO and kTKO mice could potentially bind up more
VEGF-A from the circulation. Increased skin angiogenesis
might also adversely affect hindlimb blood ﬂow and therefore
interfere with tissue repair. This possibility was illuminated
by an earlier study showing that robust skin angiogenesis
reduced perfusion within other organs such as kidney and
liver by diverting blood to the skin.45 Although these are
plausible explanations, possibilities of HIF-independent
effects are not ruled out, such as augmentation in the activa-
tion and/or expression of NF-lB and IL-8.46 Further in-
vestigations are needed to pinpoint the precise mechanisms.
Evidence for Remote Signaling
In aprevious study,wedemonstrated that globalPhd2knockout
led to robust angiogenesis throughout different tissues.9 In the
present study, we show two independent examples, in the skin
and liver, respectively, that nonischemicPHD2-deﬁcient tissues
failed to display substantial vascular growth. Although some
angiogenesis was observed in the skin, it wasmodest compared
with what was observed in global Phd2 knockout mice. This
controversy might be explained by hypothesizing that much of
angiogenesis after global Phd2 knockout was due to systemic
effects mediated by plasma VEGF-A, which was robustly
increased. However, kDKO and kTKO clearly activated para-
crine angiogenic mechanisms in skin tissues.
If we hypothesize that angiogenesis in global PHD2-
deﬁcient mice was mediated by plasma VEGF-A, a reason-
able question is why similar outcomes were not found in
kPhd2KO mice, whose plasma VEGF-A was also increased.
In this regard, it may be noted that the extent of plasma
VEGF-A increase was different between the twomouse lines.
In mice globally deﬁcient for PHD2, plasma VEGF-A levels
increased by roughly twofold, whereas the corresponding
increase in kPhd2KO mice was a relatively modest 43.3%.
Two lines of direct evidence support the existence of a
humoral mechanism in kPhd2KO mice. First, localized
Phd2 knockout in hindlimb skin tissues failed to accelerate
perfusion recovery after FAL. Second, hepatocyte-speciﬁc
Phd2 knockout not only conferred improved hindlimb
perfusion after FAL but also protected toes from necrotic
damages. These ﬁndings clearly demonstrated the existence
of a remote signaling mechanism.
Concluding Remarks
In summary, the main contribution of this study is the
demonstration that Phd2 knockout in skin tissues mayThe American Journal of Pathology - ajp.amjpathol.orgprotect vascular integrity and may improve perfusion in
ischemic hind limbs. These ﬁndings raise the possibility that
skin PHD2 may be a novel therapeutic target which can be
manipulated at a conveniently located tissue to accelerate
vascular repair and tissue regeneration in hard-to-access
organs or tissues, without undesirable neoangiogenesis
elsewhere. Given that ischemia diseases often occur in vital
organs that are accessed only through highly invasive sur-
gical procedures, the remotely protective effects deﬁned in
this study may be of signiﬁcant therapeutic potentials.
Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2013.11.032.
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